Private · Company · Aksjeselskap
Bio Pharma Norway AS
↳ Brreg · companies
MoneyNOK
Group revenue
kr 2.1M
Group net
kr -386k
Tenders won
0
Rolled up across the parent + 1 subsidiary — Fortuna Europe AS alone is kr 224k.
rollup estimate · filed konsernregnskap not yet in Intelligo
Regnskapsregisteret · rollup across ownership edges (estimate)
Group financialsNOK
- Revenue
- Net profit
| FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|
| Revenue | 1.66M | 1.56M | 1.92M | 1.87M |
| Net profit | — | — | — | -266k |
Regnskapsregisteret · company_revenue
Key figuresBrønnøysund
FY22FY23FY24FY25TREND
Revenue1665k1558k1924k1872k
Operating result-11k-197k-38k-224k
Net result———-266k
Regnskapsregisteret · company_revenue
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITOpted out of audit (fravalg) on 8 Dec 2017.
GROUPFiles as a parent with 1 subsidiaries.
BALANCEEquity kr 1.22M.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose